Upenn

Philadelphia, Pennsylvania 19107

2 studies enrolling now · 19 studies all time

What they study most

Adjunctive Treatment of Major Depressive Disorder, Advanced Cancer, Aneurysm, Brain, Apical Periodontitis, Autism Spectrum Disorder, Avascular Necrosis, Breast Diseases, Breast Neoplasms, Carcinoma, Intraductal, Noninfiltrating, Chronic Idiopathic Thrombocytopenic Purpura, Colorectal Cancer, Cutaneous Melanoma

Studies at this site

• A Trial of LNS8801 With or Without Pembrolizumab in Patients With Refractory Melanoma — Recruiting now
• Impact of Obicetrapib and Obicetrapib Plus Repatha on Lp(a) Levels — Recruiting now
• BOLT: Study of the Indigo® Aspiration System When Used in Patients With Deep Vein Thrombosis — Running, not enrolling
• Abbreviate or FAST Breast MRI for Supplemental Breast Cancer Screening for Black Women at Average Risk and Dense Breasts — Running, not enrolling
• Abbreviated Breast MRI After Cancer Treatment — Completed
• Tau PET Imaging in the NACC Study Cohort — Running, not enrolling
• AIR-B4: Mind the Gap — Running, not enrolling
• Ceramic-on-Ceramic (COC) 36mm Acetabular Bearing Insert Post Approval Study-New Subjects (COC36mmPAS) — Completed
• Assessing the WAVE Extra Soft Coil in Intracranial Aneurysms and Comparing Imaging Modalities — Completed
• Testing the Persuasiveness of Pro-inoculation Arguments — Completed
• Bone Regenerative Techniques in Endodontic Microsurgery — Completed
• Physician Assessment of the Clinical Utility of a Patient-Specific 3D Electro-Anatomical Heart Model in VT Ablation — Stopped early
• Mind the Gap (AIR-B3) — Completed
• Building Better Bridges Randomized Control Trial — Completed
• Study of Magrolimab (Hu5F9-G4) in Combination With Cetuximab in Participants With Solid Tumors and Advanced Colorectal Cancer — Completed
• 28mm Ceramic-on-Ceramic Total Hip Replacement Study — Stopped early
• Study to Evaluate the Efficacy and Safety of Adjunctive Pimavanserin in Major Depressive Disorder (CLARITY) — Completed
• Study of AKR-501 Tablets Taken Orally Once Daily for 28 Days in Patients With Chronic Idiopathic Thrombocytopenic Purpura (ITP) — Completed
• RDEA119 and Sorafenib Combination Dose Escalation Study — Completed